Operaciones Fresenius Medical Care AG & Co KGaA - FME CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.13 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.019974% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.002248% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | EUR | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | Germany | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Fresenius Medical Care AG & Co KGaA ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Estadísticas clave
| Cierre previo* | 40.02 |
| Abrir* | 39.85 |
| Cambio de 1 año* | -29.52% |
| Rango del día* | 39.85 - 40.17 |
| Rango de 52 semanas | 25.95-57.00 |
| Volumen medio (10 días) | 457.23K |
| Volumen medio (3 meses) | 13.40M |
| Capitalización de mercado | 11.72B |
| Ratio P/E | 19.45 |
| Acciones en circulación | 293.41M |
| Ingresos | 19.55B |
| EPS | 2.05 |
| Dividendo (Rendimiento %) | 2.8035 |
| Beta | 0.86 |
| Próxima fecha de resultados | Aug 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| May 31, 2023 | 40.02 | 0.02 | 0.05% | 40.00 | 40.13 | 39.56 |
| May 30, 2023 | 40.08 | -0.75 | -1.84% | 40.83 | 41.16 | 40.00 |
| May 29, 2023 | 40.37 | 0.08 | 0.20% | 40.29 | 40.92 | 39.96 |
| May 26, 2023 | 40.22 | -0.12 | -0.30% | 40.34 | 40.47 | 39.41 |
| May 25, 2023 | 40.61 | -0.55 | -1.34% | 41.16 | 41.60 | 40.54 |
| May 24, 2023 | 40.99 | -0.87 | -2.08% | 41.86 | 42.20 | 40.87 |
| May 23, 2023 | 42.46 | -0.34 | -0.79% | 42.80 | 42.96 | 41.51 |
| May 22, 2023 | 42.53 | -0.43 | -1.00% | 42.96 | 43.25 | 42.48 |
| May 19, 2023 | 43.18 | 0.83 | 1.96% | 42.35 | 43.47 | 42.34 |
| May 18, 2023 | 42.13 | -0.97 | -2.25% | 43.10 | 43.58 | 41.84 |
| May 17, 2023 | 42.93 | 0.08 | 0.19% | 42.85 | 43.23 | 42.28 |
| May 16, 2023 | 43.50 | -0.24 | -0.55% | 43.74 | 44.28 | 43.42 |
| May 15, 2023 | 43.65 | 0.06 | 0.14% | 43.59 | 43.75 | 42.95 |
| May 12, 2023 | 43.77 | -0.30 | -0.68% | 44.07 | 44.47 | 43.71 |
| May 11, 2023 | 43.97 | -0.64 | -1.43% | 44.61 | 44.91 | 43.67 |
| May 10, 2023 | 44.52 | 2.24 | 5.30% | 42.28 | 44.81 | 42.28 |
| May 9, 2023 | 42.40 | -0.43 | -1.00% | 42.83 | 43.51 | 42.00 |
| May 8, 2023 | 42.39 | 0.00 | 0.00% | 42.39 | 42.48 | 41.94 |
| May 5, 2023 | 42.39 | 0.09 | 0.21% | 42.30 | 42.76 | 41.68 |
| May 4, 2023 | 42.04 | -0.85 | -1.98% | 42.89 | 43.14 | 42.00 |
Fresenius Medical Care AG & Co KGaA Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Friday, July 14, 2023 | ||
| Hora (UTC) (UTC) 10:59 | País DE
| Evento Fresenius Medical Care AG & Co KGaA Extraordinary Shareholders Meeting Fresenius Medical Care AG & Co KGaA Extraordinary Shareholders MeetingForecast -Previous - |
| Wednesday, August 2, 2023 | ||
| Hora (UTC) (UTC) 05:00 | País DE
| Evento Q2 2023 Fresenius Medical Care AG & Co KGaA Earnings Release Q2 2023 Fresenius Medical Care AG & Co KGaA Earnings ReleaseForecast -Previous - |
| Hora (UTC) (UTC) 10:59 | País DE
| Evento Q2 2023 Fresenius Medical Care AG & Co KGaA Earnings Call Q2 2023 Fresenius Medical Care AG & Co KGaA Earnings CallForecast -Previous - |
| Thursday, November 2, 2023 | ||
| Hora (UTC) (UTC) 10:59 | País DE
| Evento Q3 2023 Fresenius Medical Care AG & Co KGaA Earnings Call Q3 2023 Fresenius Medical Care AG & Co KGaA Earnings CallForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
| Ingresos | 19398 | 17618.7 | 17859.1 | 17476.6 | 16546.9 |
| Coste de los ingresos, total | 14087.8 | 12541.7 | 12321.6 | 12080.7 | 11392.1 |
| Beneficio bruto | 5310.25 | 5077.03 | 5537.44 | 5395.85 | 5154.74 |
| Gastos totales de explotación | 17886.3 | 15766.4 | 15554.7 | 15207 | 13509.1 |
| Gastos de venta/general/administración Gastos, total | 3528.86 | 2996.98 | 3102.8 | 2939.13 | 2709.78 |
| Investigación y desarrollo | 218.63 | 214.345 | 188.75 | 164.976 | 133.274 |
| Depreciation / Amortization | 9.994 | 6.437 | 5.024 | 3.052 | 0.341 |
| Gasto (ingreso) por intereses - Explotación neta | 29.864 | -26.024 | -115.456 | -73.611 | -65.408 |
| Gastos (ingresos) extraordinarios | 11.147 | 33.005 | 51.92 | 92.744 | -661.043 |
| Ingresos de explotación | 1511.76 | 1852.29 | 2304.41 | 2269.56 | 3037.8 |
| Ingresos por intereses (gastos), netos No operativos | -292.476 | -280.429 | -368.019 | -429.444 | -301.062 |
| Ingresos netos antes de impuestos | 1219.28 | 1571.86 | 1936.39 | 1840.11 | 2736.74 |
| Ingresos netos después de impuestos | 894.325 | 1219.03 | 1435.83 | 1438.5 | 2225.66 |
| Intereses menores | -220.92 | -249.72 | -271.455 | -238.881 | -243.733 |
| Beneficio neto antes de partidas extra. Elementos | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
| Ingresos netos | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
| Beneficio neto diluido | 673.405 | 969.308 | 1164.38 | 1199.62 | 1981.92 |
| Promedio ponderado de acciones diluidas | 293.246 | 292.945 | 294.056 | 302.691 | 307.275 |
| BPA diluido sin partidas extraordinarias | 2.29638 | 3.30884 | 3.95972 | 3.96318 | 6.45 |
| Dividends per Share - Common Stock Primary Issue | 1.12 | 1.35 | 1.34 | 1.2 | 1.17 |
| BPA normalizado diluido | 3.98317 | 3.79414 | 4.71608 | 4.2027 | 4.70044 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 4704.22 | 4996.8 | 5096.17 | 4756.68 | 4548.37 |
| Ingresos | 4704.22 | 4996.8 | 5096.17 | 4756.68 | 4548.37 |
| Coste de los ingresos, total | 3555.08 | 3649.28 | 3737.58 | 3410.63 | 3374.51 |
| Beneficio bruto | 1149.14 | 1347.52 | 1358.59 | 1346.05 | 1173.85 |
| Gastos totales de explotación | 4443.28 | 4644.87 | 4624.52 | 4416.17 | 4200.7 |
| Gastos de venta/general/administración Gastos, total | 782.154 | 954.297 | 989.607 | 969.489 | 789.973 |
| Investigación y desarrollo | 53.332 | 59.237 | 58.452 | 53.334 | 47.607 |
| Depreciation / Amortization | 2.428 | 2.812 | 3.032 | 2.084 | 2.066 |
| Gasto (ingreso) por intereses - Explotación neta | -27.514 | -19.257 | -17.448 | -19.367 | -10.487 |
| Ingresos de explotación | 260.937 | 351.934 | 471.643 | 340.51 | 347.668 |
| Ingresos por intereses (gastos), netos No operativos | -82.572 | -75.315 | -76.485 | -71.579 | -69.097 |
| Ingresos netos antes de impuestos | 178.365 | 276.619 | 395.158 | 268.931 | 278.571 |
| Ingresos netos después de impuestos | 133.853 | 193.582 | 282.932 | 206.005 | 211.806 |
| Intereses menores | -47.491 | -54.778 | -52.832 | -58.865 | -54.445 |
| Beneficio neto antes de partidas extra. Elementos | 86.362 | 138.804 | 230.1 | 147.14 | 157.361 |
| Ingresos netos | 86.362 | 138.804 | 230.1 | 147.14 | 157.361 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 86.362 | 138.804 | 230.1 | 147.14 | 157.361 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 86.362 | 138.804 | 230.1 | 147.14 | 157.361 |
| Beneficio neto diluido | 86.362 | 138.804 | 230.1 | 147.14 | 157.361 |
| Promedio ponderado de acciones diluidas | 293.413 | 293.415 | 293.413 | 293.145 | 293.007 |
| BPA diluido sin partidas extraordinarias | 0.29434 | 0.47306 | 0.78422 | 0.50194 | 0.53706 |
| Dividends per Share - Common Stock Primary Issue | 0 | 1.12 | 0 | 0 | 0 |
| BPA normalizado diluido | 0.73771 | 1.47121 | 0.42868 | 0.70576 | 0.67779 |
| Gastos (ingresos) extraordinarios | 80.353 | -1.503 | -146.699 | -3.767 | |
| Other Operating Expenses, Total | -2.548 | 0.794 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 8203.46 | 7967.24 | 7275.31 | 7165.15 | 7846.89 |
| Efectivo e inversiones a corto plazo | 1443.77 | 1618.02 | 1243.23 | 1141.05 | 2265.14 |
| Cash | 911.015 | 925.134 | 746.851 | 768.706 | 831.885 |
| Efectivo y Equivalentes | 362.772 | 556.521 | 334.688 | 239.017 | 1313.75 |
| Inversiones a corto plazo | 169.983 | 136.362 | 161.688 | 133.322 | 119.507 |
| Total deudores, neto | 3882.04 | 3769.23 | 3579.29 | 3969.26 | 3765.57 |
| Accounts Receivable - Trade, Net | 3574.27 | 3409.06 | 3153.04 | 3421.35 | 3337.71 |
| Total Inventory | 2296.21 | 2038.01 | 1895.31 | 1663.28 | 1466.8 |
| Prepaid Expenses | 410.334 | 377.907 | 374.081 | 178.474 | 135.729 |
| Other Current Assets, Total | 171.093 | 164.07 | 183.398 | 213.086 | 213.646 |
| Total Assets | 35754.1 | 34366.6 | 31689 | 32934.7 | 26242.3 |
| Property/Plant/Equipment, Total - Net | 8339.81 | 8551.47 | 8186.75 | 8515.4 | 3836.01 |
| Property/Plant/Equipment, Total - Gross | 17936.7 | 16654.3 | 14830.4 | 14413.4 | 8507.4 |
| Accumulated Depreciation, Total | -9596.91 | -8102.86 | -6643.68 | -5897.98 | -4671.39 |
| Goodwill, Net | 15791.2 | 14361.6 | 12958.7 | 14017.3 | 12209.6 |
| Intangibles, Net | 1518.68 | 1459.39 | 1381.01 | 1426.33 | 681.331 |
| Long Term Investments | 773.724 | 786.905 | 761.113 | 696.872 | 649.78 |
| Other Long Term Assets, Total | 1127.27 | 1239.97 | 1126.12 | 1113.74 | 1018.66 |
| Total Current Liabilities | 6467.31 | 7257.63 | 6159.64 | 7007.23 | 6268.28 |
| Accounts Payable | 813.255 | 736.069 | 731.993 | 716.526 | 641.271 |
| Accrued Expenses | 2183.85 | 2225.56 | 2115.75 | 1964.24 | 2056.49 |
| Notes Payable/Short Term Debt | 669.013 | 1255.85 | 79.27 | 1171.85 | 1394.19 |
| Current Port. of LT Debt/Capital Leases | 1367.89 | 1329.54 | 1617.52 | 2086.16 | 1244.73 |
| Other Current Liabilities, Total | 1433.31 | 1710.61 | 1615.11 | 1068.46 | 931.597 |
| Total Liabilities | 21764.7 | 21667.8 | 20474 | 20976.8 | 14483.9 |
| Total Long Term Debt | 11175.7 | 10734.8 | 10683.2 | 10524.6 | 5045.52 |
| Long Term Debt | 7170.73 | 6646.95 | 6800.1 | 6458.32 | 5018.76 |
| Capital Lease Obligations | 4004.94 | 4087.8 | 3883.13 | 4066.3 | 26.757 |
| Deferred Income Tax | 936.475 | 868.452 | 785.886 | 739.702 | 626.521 |
| Minority Interest | 1459.73 | 1280.25 | 1116.23 | 1269.32 | 1143.55 |
| Other Liabilities, Total | 1725.47 | 1526.68 | 1728.96 | 1435.95 | 1399.99 |
| Total Equity | 13989.5 | 12698.8 | 11215.1 | 11957.9 | 11758.4 |
| Common Stock | 293.413 | 293.004 | 292.877 | 304.437 | 307.879 |
| Additional Paid-In Capital | 3372.8 | 2891.28 | 2872.63 | 3607.66 | 3873.34 |
| Retained Earnings (Accumulated Deficit) | 10711.7 | 10826.1 | 10254.9 | 9454.86 | 8831.93 |
| Treasury Stock - Common | 0 | -370.502 | -50.993 | ||
| Other Equity, Total | -388.468 | -1311.64 | -2205.34 | -1038.55 | -1203.75 |
| Total Liabilities & Shareholders’ Equity | 35754.1 | 34366.6 | 31689 | 32934.7 | 26242.3 |
| Total Common Shares Outstanding | 293.413 | 293.004 | 292.877 | 298.329 | 306.879 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 8561.71 | 8203.46 | 8512.67 | 8104.9 | 8039.39 |
| Efectivo e inversiones a corto plazo | 1223.89 | 1273.79 | 1113.55 | 1024.67 | 1173.34 |
| Efectivo y Equivalentes | 1223.89 | 1273.79 | 1113.55 | 1024.67 | 1173.34 |
| Total deudores, neto | 3995.29 | 3714.34 | 3972.16 | 3804.97 | 3890.82 |
| Accounts Receivable - Trade, Net | 3905.92 | 3574.27 | 3815.37 | 3664.28 | 3707.49 |
| Total Inventory | 2328.03 | 2296.21 | 2409.68 | 2278.86 | 2136.96 |
| Other Current Assets, Total | 1014.51 | 919.112 | 1017.27 | 996.402 | 838.272 |
| Total Assets | 35500.5 | 35754.1 | 38406.4 | 36069.7 | 34724.1 |
| Property/Plant/Equipment, Total - Net | 8081.88 | 8339.81 | 9095.34 | 8859.63 | 8510.45 |
| Goodwill, Net | 15478.4 | 15791.2 | 17187.1 | 15590.7 | 14628.7 |
| Intangibles, Net | 1416.8 | 1518.68 | 1603.8 | 1553.79 | 1480.42 |
| Long Term Investments | 798.025 | 773.724 | 767.699 | 734.734 | 798.947 |
| Other Long Term Assets, Total | 1163.7 | 1127.27 | 1239.82 | 1225.99 | 1266.2 |
| Total Current Liabilities | 6491.84 | 6467.31 | 6357.39 | 6876.55 | 6377.45 |
| Accounts Payable | 822.336 | 813.255 | 828.09 | 837.016 | 790.236 |
| Accrued Expenses | 3322.33 | 3355.14 | 3878.43 | 3596.74 | 3515.83 |
| Notes Payable/Short Term Debt | 712.94 | 669.013 | 582.523 | 1414.07 | 1115.21 |
| Current Port. of LT Debt/Capital Leases | 1354.96 | 1367.89 | 790.326 | 761.771 | 730.959 |
| Other Current Liabilities, Total | 279.268 | 262.015 | 278.022 | 266.953 | 225.212 |
| Total Liabilities | 21672.6 | 21764.7 | 23355 | 22020.5 | 21489.6 |
| Total Long Term Debt | 11197.9 | 11175.7 | 12412.7 | 11483.3 | 11497.2 |
| Long Term Debt | 7327.59 | 7170.73 | 8068.49 | 7263.56 | 7451.79 |
| Capital Lease Obligations | 3870.32 | 4004.94 | 4344.2 | 4219.74 | 4045.41 |
| Deferred Income Tax | 900.165 | 936.475 | 994.803 | 936.291 | 896.38 |
| Minority Interest | 1399.03 | 1459.73 | 1683.96 | 1401.52 | 1304.8 |
| Other Liabilities, Total | 1683.67 | 1725.47 | 1906.18 | 1322.85 | 1413.8 |
| Total Equity | 13827.9 | 13989.5 | 15051.4 | 14049.2 | 13234.5 |
| Common Stock | 293.413 | 293.413 | 293.413 | 293.413 | 293.027 |
| Additional Paid-In Capital | 3365.09 | 3372.8 | 3360.75 | 2919.91 | 2891.74 |
| Retained Earnings (Accumulated Deficit) | 10851.4 | 10711.7 | 10478.5 | 10801.6 | 11027.2 |
| Other Equity, Total | -682.02 | -388.468 | 918.768 | 34.262 | -977.445 |
| Total Liabilities & Shareholders’ Equity | 35500.5 | 35754.1 | 38406.4 | 36069.7 | 34724.1 |
| Total Common Shares Outstanding | 293.413 | 293.413 | 293.413 | 293.004 | 293.027 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 894.325 | 1219.03 | 1435.83 | 1438.5 | 2225.66 |
| Efectivo de actividades de explotación | 2167.38 | 2489.5 | 4233.16 | 2566.95 | 2061.91 |
| Efectivo de actividades de explotación | 1838.36 | 1623.68 | 1785.9 | 1593.16 | 724.847 |
| Deferred Taxes | -41.471 | 67.259 | 111.104 | 64.266 | 89.171 |
| Partidas no monetarias | 126.649 | 232.342 | 215.137 | 304.705 | -824.73 |
| Cash Taxes Paid | 334.615 | 345.052 | 301.663 | 387.719 | 358.386 |
| Intereses pagados en efectivo | 350.681 | 341.629 | 379.994 | 470.223 | 311.971 |
| Cambios en el capital circulante | -650.487 | -652.807 | 685.184 | -833.68 | -153.034 |
| Efectivo de actividades de inversión | -734.725 | -1196.23 | -1334.94 | -3285.99 | -245.039 |
| Gastos de capital | -770.336 | -886.715 | -1085.23 | -1162.76 | -1142.38 |
| Otras partidas de flujo de caja de inversión, total | 35.611 | -309.513 | -249.709 | -2123.22 | 897.34 |
| Efectivo procedente de actividades de financiación | -1617.36 | -1024.38 | -2664.03 | -466.633 | -681.736 |
| Elementos de flujo de caja de financiación | -123.95 | -279.535 | -693.531 | 153.387 | -528.009 |
| Total Cash Dividends Paid | -395.556 | -392.455 | -351.17 | -354.636 | -324.838 |
| Emisión (retiro) de acciones, neto | 20.153 | 6.511 | -353.335 | -583.932 | 10.183 |
| Emisión (amortización) de deuda, neta | -1118.01 | -358.903 | -1265.99 | 318.548 | 160.928 |
| Efectos del cambio de divisas | -23.162 | 131.228 | -160.371 | 47.76 | 32.387 |
| Variación neta de la tesorería | -207.868 | 400.116 | 73.816 | -1137.91 | 1167.52 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 133.853 | 894.325 | 700.743 | 417.811 | 211.806 |
| Cash From Operating Activities | 142.835 | 2167.38 | 1567.72 | 910.11 | 158.697 |
| Cash From Operating Activities | 437.814 | 1838.36 | 1343.69 | 841.707 | 418.957 |
| Deferred Taxes | -22.373 | -41.471 | -60.08 | -63.14 | -9.295 |
| Non-Cash Items | 29.157 | 126.649 | 103.348 | 193.575 | 54.974 |
| Cash Taxes Paid | 33.575 | 334.615 | 233.758 | 197.797 | 44.301 |
| Cash Interest Paid | 77.255 | 350.681 | 238.716 | 138.032 | 79.484 |
| Changes in Working Capital | -435.616 | -650.487 | -519.981 | -479.843 | -517.745 |
| Cash From Investing Activities | -163.277 | -734.725 | -509.78 | -408.988 | -211.316 |
| Capital Expenditures | -146.326 | -723.988 | -534.505 | -395.112 | -198.313 |
| Other Investing Cash Flow Items, Total | -16.951 | -10.737 | 24.725 | -13.876 | -13.003 |
| Cash From Financing Activities | 2.014 | -1617.36 | -1497.44 | -994.912 | -266.641 |
| Financing Cash Flow Items | 150.852 | -123.95 | -128.948 | 73.638 | 464.211 |
| Issuance (Retirement) of Stock, Net | 0 | 20.153 | 20.151 | 20.145 | 0.792 |
| Issuance (Retirement) of Debt, Net | -148.838 | -1118.01 | -993.091 | -693.139 | -731.644 |
| Foreign Exchange Effects | -31.469 | -23.162 | 71.401 | 36.807 | 10.947 |
| Net Change in Cash | -49.897 | -207.868 | -368.103 | -456.983 | -308.313 |
| Total Cash Dividends Paid | -395.556 | -395.556 | -395.556 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Fresenius SE & Co KGaA | Corporation | 32.1663 | 94380382 | 0 | 2023-02-21 | |
| Pzena Investment Management, LLC | Investment Advisor/Hedge Fund | 5.2 | 15257499 | 3311 | 2023-01-02 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.1 | 12030043 | -14667 | 2023-04-25 | LOW |
| Harris Associates L.P. | Investment Advisor/Hedge Fund | 3.0098 | 8831173 | 15678 | 2023-02-28 | LOW |
| Dodge & Cox | Investment Advisor/Hedge Fund | 3.0017 | 8807448 | -5315479 | 2023-01-03 | LOW |
| Artisan Partners Limited Partnership | Investment Advisor | 2.9941 | 8785062 | 0 | 2023-01-02 | LOW |
| Templeton Investment Counsel, L.L.C. | Investment Advisor/Hedge Fund | 2.6016 | 7633561 | 23467 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.9794 | 5807904 | 36859 | 2023-04-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.2147 | 3564186 | -379946 | 2022-12-31 | LOW |
| Fidelity International | Investment Advisor | 0.9935 | 2915020 | 70145 | 2023-03-31 | LOW |
| Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9427 | 2766009 | -60320 | 2023-04-30 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.7852 | 2303961 | 2129 | 2023-04-30 | LOW |
| BlackRock Asset Management Deutschland AG | Investment Advisor | 0.7728 | 2267616 | 11240 | 2023-04-30 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5825 | 1709038 | -29083 | 2023-04-30 | LOW |
| Macquarie Investment Management | Investment Advisor | 0.5166 | 1515681 | -81890 | 2023-04-30 | LOW |
| Fiduciary Management, Inc. | Investment Advisor | 0.506 | 1484650 | 0 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.5005 | 1468406 | 8937 | 2023-04-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4635 | 1360101 | 51 | 2023-04-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.42 | 1232368 | -1381 | 2023-04-30 | LOW |
| Lazard Fund Managers (Ireland) Limited | Investment Advisor | 0.3975 | 1166355 | -2781 | 2023-02-28 | HIGH |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Fresenius Medical Care Company profile
Sobre Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA es una compañía de diálisis renal. La Compañía brinda atención de diálisis y servicios relacionados a personas que sufren de enfermedad renal en etapa terminal (ESRD), así como a otros servicios de atención médica. Los segmentos de la compañía incluyen el Segmento de América del Norte, el Segmento de Europa, Medio Oriente y África (EMEA), el Segmento de Asia y el Pacífico y el Segmento de América Latina. La compañía desarrolla y fabrica una gama de máquinas de diálisis, sistemas y productos desechables. Al 31 de diciembre de 2016, la Compañía vendió sus productos a clientes en más de 120 países y también los utilizó en sus operaciones internas de servicios de atención médica. Los servicios de coordinación de la atención de la compañía incluyen la prestación coordinada de servicios de farmacia, servicios especializados vasculares, cardiovasculares y endovasculares, servicios de pruebas de laboratorio sin diálisis, servicios médicos, servicios hospitalarios e intensivistas, servicios de planes de salud, servicios de centros de cirugía ambulatoria y servicios de atención de urgencia.
El precio actual de la acción Fresenius Medical Care AG & Co KGaA en tiempo real es 40.06 EUR. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Manhattan Associates, VirTra, LMP Automotive Holdings, Inc., Chemours, AusGroup y Veeco. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Healthcare Facilities & Services (NEC) |
Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com